Redeye retains its positive view of Proact following a strong Q4 report fueled by System sales. However, the organic growth in recurring revenue accelerated as well. We raise our forecasts and Base Case slightly.
ANNONS
Redeye retains its positive view of Proact following a strong Q4 report fueled by System sales. However, the organic growth in recurring revenue accelerated as well. We raise our forecasts and Base Case slightly.